Advertisements

Папазол

Quick links to important sections

Папазол

Selected form

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Папазол

Property Description
Active ingredients Bendazol, Papaverine
Form Tablet
Pharmacological class Antihypertensive and Antispasmodic Agent
Common purpose Relief of muscle spasm and blood pressure support
Origin Partially Synthetic

1. Defining Папазол: Identity, Type, and Form

Папазол is a multicomponent drug and a fixed-dose combination product supplied as a tablet for oral administration. It is classified within the high-level pharmacological class of antihypertensive and antispasmodic agents. This combination is clinically recognized for its ability to address both vascular tension and smooth muscle spasm simultaneously.

The drug's structure is specifically designed to integrate the therapeutic effects of its two distinct active ingredients. This dual functionality defines this combination drug and separates it from single-agent therapies that focus solely on either blood pressure regulation or muscle relaxation.

2. Composition and Pharmaceutical Origin

The core composition includes the two active ingredients: Bendazol (known by the synonym Dibazol) and Papaverine (Papaverine hydrochloride). The preparation is characterized as partially synthetic: Bendazol is a synthetic compound belonging to the benzimidazole chemical class, noted for its ability to reduce blood vessel tension.

Papaverine, conversely, is a benzylisoquinoline alkaloid, chemically derived from a class of substances that exert strong relaxing effects on muscle tissue. The active ingredients are blended with inactive excipients necessary to create the final solid tablet form. The unique combination of Bendazol and Papaverine establishes the distinctive profile of this formulation.

3. General Therapeutic Purpose and Combined Action

The general therapeutic purpose of Папазол is to achieve simultaneous direct smooth muscle relaxation and widespread vasodilation in the body. This combined action is central to its utility: Papaverine acts to relieve involuntary spasms, while Bendazol works as a vasodilator that reduces peripheral resistance.

The fundamental general benefit is the ability to alleviate the excessive tension and spasm associated with smooth muscle contraction while concurrently providing support for the maintenance of normal blood pressure levels. The fixed-dose format ensures these two effects are delivered in a coordinated manner.

Advertisements

What side effects are possible with Папазол?

Possible Side Effects and Safety Information

The safety profile for this combination medicine is established through regulatory documents that classify potential adverse effects based on frequency and affected body systems, as well as by defining specific use limitations.

Officially Documented Adverse Reactions

Side effects are generally categorized into groups affecting specific systems or organs, such as Cardiovascular (changes in blood pressure or heart rate), Nervous System (headache, drowsiness, vertigo, malaise), and Gastrointestinal (nausea, abdominal discomfort, constipation, diarrhea). Other reported reactions include skin rash, flushing, and increased perspiration.

Serious Adverse Reactions and Safety Restrictions

Serious or clinically significant reactions that have been reported include signs of hepatic hypersensitivity, such as jaundice (yellowing of the skin or eyes) and elevated liver enzyme values; therapy is formally required to be discontinued if such symptoms become evident. Hepatitis has been reported infrequently, which rarely progresses to cirrhosis.

Regulatory documents define formal contraindications—situations where the drug is strictly prohibited—including known hypersensitivity to the drug’s components, as well as specific severe conditions such as complete atrioventricular heart block.

Population and Use Considerations

The medicine is subject to safety precautions in certain patient groups, with official labeling advising caution in patients with recent severe head trauma, severely impaired liver function, severely impaired kidney function, and in the elderly. Safety and effectiveness in children have not been established by some major regulatory bodies, restricting its authorized use in this population.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for a Papazol overdose is defined by the potential for serious toxicity related to its components. Documented overdose presentations often involve signs of vasomotor instability, including generalized weakness, nausea, vomiting, dizziness, and heavy sweating. Central nervous system effects can range from simple drowsiness and double vision to severe complications like seizures and life-threatening apnoea (cessation of breathing).

The most severe documented outcomes affect the cardiovascular system. Overdosing carries the potential for serious arrhythmias, including paroxysmal tachycardia, and the depression of atrioventricular and intraventricular conduction. Large oral exposures are also officially associated with severe systemic disturbances, including metabolic acidosis, hyperglycemia, and hypokalemia.

Immediate action is mandatory when overdose is suspected. Due to the high risk of life-threatening events, the official guidance explicitly mandates that individuals must seek emergency medical attention immediately. Management is symptomatic and supportive, requiring meticulous hospital monitoring of vital signs, blood gases, and blood chemistry values. No specific antidote is officially documented for Papazol overdose, underscoring the necessity of urgent professional supportive care.

Advertisements

Therapeutic Uses of Папазол

What Papazol Treats: Main Uses and Benefits

Papazol is a combination medication containing Papaverine and Bendazol. The primary therapeutic use of this medication is centered on its function as a component applied in addressing symptoms related to heightened physiological activity and tension. It is commonly used to help with symptomatic relief that assists patients during episodes associated with increased physiological stress. This action is considered relevant in contexts involving heightened systemic burden and localized discomfort.

Papaverine may assist with symptomatic relief in situations where patients experience functional stability becoming affected due to the underlying conditions. The medication is commonly used to help with symptomatic relief across conditions characterized by periods of heightened symptoms, which may include systemic imbalance or localized physiological strain. This supports the management of symptoms that interfere with daily functioning. The overall application helps address symptom clusters that may become intense or disruptive. The supportive effect generally contributes to improved comfort during periods of heightened symptoms.

Quick Fact: Supports Comfort During Symptomatic Phases

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Папазол?

Eligibility to use Папазол (Papaverine and Bendazol) is determined by strict population-based rules found in official regulatory labeling, primarily concerning its Papaverine component. The medicine is contraindicated and must not be used by specific patient groups.


Contraindicated Populations

The following conditions define non-eligibility for use:

  • Complete Atrioventricular (AV) Heart Block
  • Parkinson's disease
  • Known Hypersensitivity to the active ingredients.

Restricted and Conditional Use

Use is permitted only with caution and monitoring in patients with conditions such as Hepatic Impairment/Liver Disease, Glaucoma, unstable cardiovascular disease, or after a recent Myocardial Infarction or Stroke.


Age-Specific Eligibility

The Adult Population has established use. For the Pediatric Population (Children), safety and effectiveness have not been established. Older Adults (Geriatric) may require caution as the medication may reduce tolerance to cold temperatures.


Pregnancy and Lactation

Official labeling classifies the drug as Pregnancy Category C, meaning it should only be used if clearly needed. Use requires caution in nursing mothers.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents describe several important interactions for Papazol (which contains Dibazole and Papaverine). These interactions primarily involve changes to the effectiveness and safety profile when taken alongside specific drug classes.

Interactions Resulting in Enhanced Effects:

  • Antihypertensive Agents, Diuretics, Vasodilators, and Tricyclic Antidepressants: Concomitant use with these drug categories may potentiate, or increase, the blood pressure-lowering (hypotensive) effect of Papazol.
  • Drugs that Depress the Central Nervous System (CNS): Combining Papazol with CNS depressants may lead to an enhancement of the overall sedative or depressant effects.

Interactions Resulting in Reduced Effects:

  • Adsorbents and Astringents: These agents may reduce the absorption of Papazol from the gastrointestinal tract, potentially lowering its effectiveness.
  • Barbiturates: Concurrent use with barbiturates may reduce the spasmolytic effect of the Papaverine component within Papazol.
  • Agents that Increase Acetylcholinesterase Activity: These drugs may reduce the action of the Dibazole component.

Interaction Restrictions:

  • Alcohol (Ethanol): The use of Papazol with alcohol is restricted due to the increased risk of a severe drop in blood pressure and increased CNS depression.
Advertisements

Mechanism of Action

Dual-Targeting of Intracellular Signaling (PDE and NO Pathways)

This combination product utilizes two distinct molecular strategies that result in smooth muscle relaxation. The Papaverine component acts as a non-selective inhibitor of Phosphodiesterase ( PDE) enzymes, thereby reducing the rate of hydrolysis of the relaxing cellular messengers cAMP and cGMP. Concurrently, the Bendazol component enhances the activity of Nitric Oxide Synthase ( NOS), increasing the endogenous generation of Nitric Oxide ( NO). These dual mechanisms converge to modulate the cellular signals that drive muscle contraction.


Regulation of Calcium Availability and Vascular Tone

The collective action of elevated cAMP and cGMP levels in the smooth muscle cells triggers a cascade that results in a reduction in the concentration of free intracellular calcium ( Ca^2+). Since Ca^2+ is the essential trigger for all muscle contraction, its reduction leads to a widespread relaxation of both vascular and visceral smooth muscle. This physiological change results in a decrease in Peripheral Vascular Resistance ( PVR), reflecting a reduction in arterial tension.

Advertisements

Dosage and Administration Information

How to use Папазол: Official Administration Guidelines

The usage of Папазол (a fixed-dose combination of 30 mg Bendazol and 30 mg Papaverine) is governed by official prescribing instructions. These guidelines establish a structured framework for administration, focusing exclusively on dose, frequency, and specific intake conditions.


Administration Scope

Instruction Detail
Route of Administration The drug is intended for oral use in the form of a tablet.
Dosing Schedule & Frequency The standard administration pattern involves taking 1 –2 tablets per dose, with a total frequency of 2 –3 times per day. The treatment course typically lasts 2 –4 weeks.
Intake Timing Official labels specify that administration may occur on an empty stomach (натощак).
Age-Group Rules Administration is authorized for adolescents over 12 years at the adult dosage. Caution is required, and smaller doses are generally indicated, for elderly patients and those with established hepatic or renal impairment.
Procedural Conditions During the period of use, alcohol consumption must be excluded. Patients are also advised to use caution when performing activities that require heightened focus, such as driving or operating machinery.

Connection to the Overall Use Protocol

The regulatory protocol for Папазол defines a clear oral, daily-divided dosing regimen. This framework sets the required quantity and frequency, and also specifies important administration conditions, such as the recommended timing relative to meals and the exclusion of alcohol, ensuring adherence to the intended therapeutic strategy.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Папазол


Evidence for Use in Mild Arterial Hypertension and Vascular Spasm

Studies explored the combination of Papaverine and Bendazol in the context of mild blood pressure elevation and spasms affecting the blood vessels. These studies have primarily taken the form of short-term randomized controlled trials (RCTs) and various observational studies, which were used in research exploring how symptoms change over time. The main focus of these trials included the monitoring of outcomes monitoring physiological strain or stress, specifically measuring changes in both systolic and diastolic blood pressure readings in adult participants.

The available research contributes to understanding patterns observed in the studied populations over short defined time intervals. Some trials reported that blood pressure readings were often measured as lower during the study period, although these observations were observed in some studies that primarily covered brief periods, such as a few weeks. The evidence contributes to understanding symptom patterns in conditions characterized by fluctuating or episodic manifestations linked to vascular activity.

Research Comparing Папазол to Placebo or Other Agents

Studies have explored how the combination drug was evaluated in a comparison against an inactive substance (a placebo) or against other older medicines used in research exploring how symptoms change over time. These trials mainly involved adult populations with mild hypertension, and they examined short-term outcomes related to systemic or functional imbalance.

Data show patterns related to measured blood pressure changes, comparing those receiving the combination to those receiving the placebo or alternative therapy. Comparative data for certain groups remain insufficient, meaning a comprehensive understanding of its performance against a wide range of modern treatments is lacking.


Long-Term Studies and Follow-Up Data

Research has primarily focused on the immediate or intermediate effects of the combination, meaning the follow-up durations were limited. Consequently, the long-term effects are not fully established, and there is limited information for long-term outcomes regarding sustained blood pressure control or the durability of the reported observations over many months or years.

What is Still Uncertain About the Research for Папазол

The current evidence landscape indicates several areas of uncertainty. The sample sizes were modest in many trials, which contributes to the fact that the certainty remains low for generalized statements about its effects. Comparative evidence against contemporary and widely used standard blood pressure medications is lacking. The limited duration of most trials means long-term effects are not fully established. Therefore, research highlights what is known — and what is still uncertain — regarding the drug combination.

Key Studies & References

  1. Papaverine Hydrochloride Drug Summary and Dosage Information (Reference for Component Properties)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Папазол (FAQ)


Q: Is Папазол considered a preventative treatment or for acute episodes?

According to official documents, the drug's approved uses include conditions characterized by acute changes, such as certain hypertensive crises. However, regulatory guidelines also establish a prescribed treatment course, typically lasting several weeks, for use in mild chronic conditions like arterial hypertension. This indicates that its documented use covers both acute relief and a structured course of treatment.


Q: Does Папазол cause a sudden drop in blood pressure?

Official product information states that the drug works by reducing peripheral vascular resistance (PVR), which is the tension in your arteries. As a consequence of this action, changes in blood pressure, including potential drops, are listed as documented adverse reactions in the safety profile. The drug's intended action is to lower blood pressure, which may result in low blood pressure.


Q: What is the risk of dependence or withdrawal symptoms with Папазол?

Regulatory documents and official product information detail the full safety profile and warnings associated with this drug. These documents do not list dependence, addiction, or withdrawal symptoms among the documented adverse reactions or special warnings.


Q: Are there any common over-the-counter medicines that interact with Папазол?

Official documents describe interactions with certain drug classes, such as adsorbents and astringents. These categories include some common over-the-counter products, such as antacids. Taking Папазол with these types of products may reduce the amount of the drug absorbed by the body, potentially lowering its effectiveness.


Q: Why do some people use Папазол for stomach cramps?

The official mechanism of action for Папазол involves relaxing smooth muscles throughout the body. This muscle-relaxing effect extends to the internal organs, which are composed of visceral smooth muscle. This fundamental function, which addresses muscle spasms, explains why the drug is sometimes used to alleviate cramps in the stomach or gut.


Q: Does taking Папазол at night affect sleep?

Official documents list nervous system effects, including drowsiness, in the safety information for Папазол. This documented side effect may influence a person's general level of wakefulness or affect sleep patterns.


Q: Are there any specific dietary restrictions while using Папазол?

The most important restriction noted in the official guidelines is the mandated exclusion of alcohol consumption during the period of use. Aside from this, official regulatory documents do not typically note other general dietary restrictions or changes to food intake that are necessary while taking the medication.


Q: Can Папазол affect the results of blood tests?

When drugs are known to interfere with medical tests, this information is typically noted in the regulatory documents. However, official information regarding Папазол does not contain explicit information describing interference with the results of general blood tests.


Q: What are the most commonly reported side effects in official documents?

Official regulatory documents classify all documented adverse reactions into categories based on their frequency of reporting. These classifications, such as common, uncommon, or rare, are used to indicate how frequently a specific side effect has been observed in studies or post-market monitoring.


Q: Can a person with known low blood pressure use Папазол safely?

Regulatory information states that the drug is intended to reduce blood pressure. Because of this intended action, official documentation advises that the drug is indicated for use with caution in patients where blood pressure is already low (hypotension).


Q: Is skin flushing or redness a common side effect of Папазол?

Skin flushing, or redness, is listed as a documented adverse reaction in the safety information for this drug. Official documents provide a classification that indicates how frequently this specific reaction has been reported.


Q: Do official patient leaflets mention specific contraindications for diabetics?

The official product documentation lists all formal contraindications and special precautions for use. Diabetes mellitus or related conditions are not listed among the formal contraindications or the special precautions found in these documents.


Q: Is it common for doctors to recommend taking Папазол with another medication?

Regulatory documents describe known interactions that lead to an enhanced blood pressure-lowering effect when Папазол is combined with certain other medications, such as antihypertensive agents. The documentation of these potentiating effects suggests co-administration is a clinically acknowledged possibility.


Q: Is Папазол a brand name or a combination of generic ingredients?

Official documentation defines Папазол as a fixed-dose combination product. It is composed of the active ingredients Bendazol and Papaverine hydrochloride, which establishes its combination structure.


Q: Is the combination of ingredients in Папазол still considered standard practice?

Summaries of research evidence indicate that comparative data against contemporary, modern standard blood pressure medications is insufficient or lacking. While the drug is still authorized, this lack of comprehensive comparative research means its standing relative to newer treatments is not fully established.

Advertisements

How should Папазол be stored and disposed of?

How to Store and Dispose of Папазол?

The official regulatory documents define the required storage and disposal conditions for Папазол tablets, which contain Bendazol and Papaverine.

Storage Conditions

Requirement Details
Temperature Limit Store at a temperature not exceeding 25mathrmC.
Environmental Protection Keep in a dry place and protected from light.
Packaging Must be stored in the original container/packaging.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Unused or expired Папазол must be disposed of in accordance with local regulatory requirements for pharmaceutical products. It is officially mandated that the medicine not be discarded with household waste or poured down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Папазол found in:

A-Z Index: